Professional Overview
Marco Dacal is an accomplished pharmaceutical industry professional with extensive experience in specialty care and oncology. As the Founder of Vacine.me and a Sócio (Partner) at 7Consulting, he leverages his deep expertise to drive innovation and strategic growth within the healthcare sector.
Experience Summary
Current Role
As the Founder of Vacine.me, Marco is responsible for overseeing the company's overall vision, strategy, and operations. He is spearheading the development of cutting-edge digital solutions to enhance patient care and improve access to essential healthcare services. Additionally, as a Sócio at 7Consulting, Marco provides strategic advisory services to clients, drawing upon his extensive industry knowledge and network.
Career Progression
Prior to his entrepreneurial endeavors, Marco held various leadership positions at Libbs Farmacêutica Ltda., a prominent Brazilian pharmaceutical company. He served as the Business Unit Director for Specialty Care, where he was instrumental in driving the company's growth and expanding its product portfolio. Previously, he held the roles of Head of Sales and Business Unit Manager for Oncology, contributing significantly to the organization's sales and market expansion strategies.
Academic Background
Marco holds a degree from a prestigious university, equipping him with a strong foundation in business and healthcare management. His academic achievements demonstrate his commitment to continuous learning and professional development.
Areas of Expertise
Marco's expertise spans several key areas, including strategic planning, sales and marketing, business development, and product portfolio management. He has a deep understanding of the Brazilian pharmaceutical industry, with a particular focus on specialty care and oncology. Additionally, he possesses strong leadership and communication skills, enabling him to effectively collaborate with cross-functional teams and key stakeholders.
Professional Impact
Throughout his career, Marco has made significant contributions to the pharmaceutical industry. As the Head of Sales at Libbs Farmacêutica Ltda., he led the implementation of innovative sales strategies that resulted in substantial revenue growth and market share expansion. As the Business Unit Director for Specialty Care, he successfully spearheaded the launch of several new products, positioning the company as a leader in the specialty care segment.
Conclusion
With his extensive industry experience, strategic vision, and entrepreneurial spirit, Marco Dacal is well-positioned to drive continued innovation and growth within the healthcare sector. As he navigates his current roles, he remains committed to leveraging his expertise to create meaningful impact and contribute to the advancement of the pharmaceutical industry in Brazil.
